Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Subst Abuse Treat. 2017 Oct 18;84:17–20. doi: 10.1016/j.jsat.2017.10.008

Table 1.

Background Characteristics by Administering Naloxone in the Past 12-Months.

Sample (n = 468) Administered Naloxone χ2 or t (p =)

No (n = 400) Yes (n = 68)
Yrs. Age 32.1 (± 8.65) 32.0 (± 8.69) 33.0 (± 8.51) -0.85 (.398)
Gender
 Female 135 (28.9%) 115 (85.2%a) 20 (14.8%a) 0.01 (.911)
 Male 333 (71.2%) 285 (85.6%) 48 (14.4%)
Years Education 11.8 (± 1.88) 11.8 (± 1.95) 11.9 (± 1.36) -0.24 (.808)
Race/Ethnicity
 Non-Hispanic White 386 (82.3%) 330 (85.5%) 56 (14.5%)
 Non-Hispanic Black 20 (4.3%) 20 (100.0%) 0 (0.0%) 9.63 (.022)
 Hispanic 42 (9.0%) 37 (88.1%) 5 (11.9%)
 Other 21 (4.5%) 14 (66.7%) 7 (33.3%)
Detoxification Drug
 Heroin 406 (86.8%) 338 (83.3%) 68 (16.8%) 12.15 (<.001)
 Other Opiates 62 (13.3%) 62 (100.0%) 0 (0.0%)
IDUa (Past 30 Days)
 No 145 (31.0%) 140 (96.6%) 5 (3.5%) 20.78 (<.001)
 Yes 323 (69.0%) 260 (80.5%) 63 (19.5%)
Ever ODb
 No 286 (61.1%) 258 (90.2%) 28 (9.8%)
 Yes 182 (38.9%) 142 (78.0%) 40 (22.0%)
Present at OD
 No 274 (58.6%) 273 (99.6%) 1 (0.4%) 106.79 (<.001)
 Yes 194 (41.5%) 127 (65.5%) 67 (34.5%)

Note: Boldface indicates statistical significance (p<0.05). Percentages were calculated within rows of the contingency table and should be compared across rows.

a

Injection drug use

b

Overdose